NZ240630A - Sulphonamides and pharmaceutical compositions thereof - Google Patents

Sulphonamides and pharmaceutical compositions thereof

Info

Publication number
NZ240630A
NZ240630A NZ240630A NZ24063091A NZ240630A NZ 240630 A NZ240630 A NZ 240630A NZ 240630 A NZ240630 A NZ 240630A NZ 24063091 A NZ24063091 A NZ 24063091A NZ 240630 A NZ240630 A NZ 240630A
Authority
NZ
New Zealand
Prior art keywords
tert
butyl
hydroxy
sulfo
denotes
Prior art date
Application number
NZ240630A
Other languages
English (en)
Inventor
Reinhard Heck
Hans Alois Dresel
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NZ240630A publication Critical patent/NZ240630A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/40—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ240630A 1990-11-22 1991-11-18 Sulphonamides and pharmaceutical compositions thereof NZ240630A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4037174A DE4037174A1 (de) 1990-11-22 1990-11-22 Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten

Publications (1)

Publication Number Publication Date
NZ240630A true NZ240630A (en) 1994-12-22

Family

ID=6418735

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ240630A NZ240630A (en) 1990-11-22 1991-11-18 Sulphonamides and pharmaceutical compositions thereof

Country Status (16)

Country Link
EP (1) EP0558569B1 (enrdf_load_stackoverflow)
JP (1) JPH06502632A (enrdf_load_stackoverflow)
AT (1) ATE117674T1 (enrdf_load_stackoverflow)
AU (1) AU659421B2 (enrdf_load_stackoverflow)
CA (1) CA2096847A1 (enrdf_load_stackoverflow)
DE (2) DE4037174A1 (enrdf_load_stackoverflow)
FI (1) FI932323L (enrdf_load_stackoverflow)
HU (1) HUT68277A (enrdf_load_stackoverflow)
IE (1) IE914044A1 (enrdf_load_stackoverflow)
IL (1) IL100120A0 (enrdf_load_stackoverflow)
MX (1) MX9102127A (enrdf_load_stackoverflow)
NZ (1) NZ240630A (enrdf_load_stackoverflow)
PT (1) PT99572A (enrdf_load_stackoverflow)
TW (1) TW264466B (enrdf_load_stackoverflow)
WO (1) WO1992009571A1 (enrdf_load_stackoverflow)
ZA (1) ZA919206B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491170A (en) * 1994-12-19 1996-02-13 Warner-Lambert Company β-carboxy sulfonamide ACAT inhibitors
EP2970124B1 (en) * 2013-03-14 2019-05-22 The Board of Trustees of the Leland Stanford Junior University Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737316A (en) * 1971-08-31 1973-06-05 Eastman Kodak Co Two-equivalent sulfonamido couplers
US3801321A (en) * 1972-07-18 1974-04-02 Eastman Kodak Co Photothermographic element,composition and process
US4013621A (en) * 1975-04-29 1977-03-22 Ciba-Geigy Corporation Substituted sulfonamide derivatives of hindered phenols and stabilized compositions
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0325245B1 (en) * 1988-01-19 1993-10-20 Tanabe Seiyaku Co., Ltd. Phenoxyacetic acid derivatives, preparation thereof, pharmaceutical compositions comprising them and use

Also Published As

Publication number Publication date
IE914044A1 (en) 1992-06-03
TW264466B (enrdf_load_stackoverflow) 1995-12-01
FI932323A7 (fi) 1993-05-21
HU9301498D0 (en) 1993-09-28
JPH06502632A (ja) 1994-03-24
DE4037174A1 (de) 1992-05-27
ZA919206B (en) 1992-08-26
DE59104443D1 (de) 1995-03-09
IL100120A0 (en) 1992-08-18
EP0558569B1 (de) 1995-01-25
FI932323A0 (fi) 1993-05-21
EP0558569A1 (de) 1993-09-08
ATE117674T1 (de) 1995-02-15
HUT68277A (en) 1995-06-28
AU8905791A (en) 1992-06-25
PT99572A (pt) 1992-10-30
WO1992009571A1 (de) 1992-06-11
CA2096847A1 (en) 1992-05-23
FI932323L (fi) 1993-05-21
AU659421B2 (en) 1995-05-18
MX9102127A (es) 1992-07-08

Similar Documents

Publication Publication Date Title
EP0178874B1 (en) Alkylsulfonamidophenylalkylamines
CZ97787A3 (en) Derivatives of indolizine, process of their preparation and pharmaceutical or veterinary composition in which said derivatives are comprised
CS208774B2 (en) Method of making the derivatives of the fenoxyalkylcarboxyl acids
AU597707B2 (en) Sulphonamide containing phenoxyacetic acid derivatives and their preparation
AU595814B2 (en) New carboxylic acid derivatives, processes for the preparation thereof, the use thereof and pharmaceutical compositions containing them
CA2253342A1 (en) Biphenylsulfonamide matrix metalloproteinase inhibitors
EP0325245B1 (en) Phenoxyacetic acid derivatives, preparation thereof, pharmaceutical compositions comprising them and use
EP0223593B1 (en) Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation
CS271469B2 (en) Method of phenoxyalkylcarboxyl acid's derivatives production
PH26828A (en) Benzonitrile derivatives pharmaceutical preparations and use thereof
US20070015745A1 (en) Cyclohexyl(alkyl)propanolamines, Preparation Method and Pharmaceutical Compositions Containing Same
US5508431A (en) 4-hydroxyphenylthio derivatives, their preparation and their use for the preparation of aminoalkoxyphenylsulphonyl derivatives
NZ240630A (en) Sulphonamides and pharmaceutical compositions thereof
JPH11222485A (ja) スルホンアミド置換ベンゾピラン誘導体、その製造法、医薬としてのその使用およびそれを含有する医薬製剤
US7102007B2 (en) Dihydroindole and tetrahydroquinoline derivatives
US4806551A (en) N-dihydroindolylethyl-sulphonamides
FI103202B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydroki noliiinijohdannaisten valmistamiseksi
US6043281A (en) Nitromethyl ketones, process for preparing them and compositions containing them
US5015657A (en) 2-halogen-substituted N-indolylethyl-sulphonamides and inhibiting platelet aggregation and antagonizing thromboxane A2 therewith
NZ241117A (en) Sulphonylaminoalkylphenylalkylamine derivatives; preparatory processes and pharmaceutical compositions
US20010018437A1 (en) Novel compounds and methods for treating multiple sclerosis
JPH11500754A (ja) 新規化合物および多発性硬化症の処置法
CN114436945A (zh) 一种苯磺酰胺类化合物、制备方法及应用
EP0946503A1 (fr) Derives du nitromethylthiobenzene comme inhibiteurs de l'aldose reductase
EP0375557A1 (en) Glycine derivative process for preparation thereof, and pharmaceutical composition containing it